Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Managing Multiple Sclerosis: Treatment Initiation, Modification, and Sequencing.

Freedman MS, Selchen D, Prat A, Giacomini PS.

Can J Neurol Sci. 2018 Jun 12:1-15. doi: 10.1017/cjn.2018.17. [Epub ahead of print]

PMID:
29893652
2.

Severe aseptic temporal lobe encephalitis on fingolimod.

Rotstein DL, Bharatha A, Selchen D.

Mult Scler Relat Disord. 2018 Apr 16;23:4-6. doi: 10.1016/j.msard.2018.04.008. [Epub ahead of print]

PMID:
29689473
3.

Quantitative spinal cord MRI in radiologically isolated syndrome.

Alcaide-Leon P, Cybulsky K, Sankar S, Casserly C, Leung G, Hohol M, Selchen D, Montalban X, Bharatha A, Oh J.

Neurol Neuroimmunol Neuroinflamm. 2018 Jan 17;5(2):e436. doi: 10.1212/NXI.0000000000000436. eCollection 2018 Mar.

4.

In-Patient Code Stroke: A Quality Improvement Strategy to Overcome Knowledge-to-Action Gaps in Response Time.

Kassardjian CD, Willems JD, Skrabka K, Nisenbaum R, Barnaby J, Kostyrko P, Selchen D, Saposnik G.

Stroke. 2017 Aug;48(8):2176-2183. doi: 10.1161/STROKEAHA.117.017622. Epub 2017 Jun 27.

PMID:
28655812
5.

Prevalence of Fabry Disease and Outcomes in Young Canadian Patients With Cryptogenic Ischemic Cerebrovascular Events.

Lanthier S, Saposnik G, Lebovic G, Pope K, Selchen D, Moore DF; Canadian Fabry Stroke Screening Initiative Study Group.

Stroke. 2017 Jul;48(7):1766-1772. doi: 10.1161/STROKEAHA.116.016083. Epub 2017 Jun 8.

6.

Decision-making in Multiple Sclerosis: The Role of Aversion to Ambiguity for Therapeutic Inertia among Neurologists (DIScUTIR MS).

Saposnik G, Sempere AP, Prefasi D, Selchen D, Ruff CC, Maurino J, Tobler PN.

Front Neurol. 2017 Mar 1;8:65. doi: 10.3389/fneur.2017.00065. eCollection 2017.

7.

Everything Old is New Again.

Florendo-Cumbermack A, Selchen D, Morrow SA, Sharma M, Steven D, Ang LC, Casserly C, Burneo J, Kremenchutzky M, Hammond R.

Can J Neurol Sci. 2016 Jan;43(1):213-8. doi: 10.1017/cjn.2015.309. No abstract available.

PMID:
27182570
8.

Decision making under uncertainty, therapeutic inertia, and physicians' risk preferences in the management of multiple sclerosis (DIScUTIR MS).

Saposnik G, Sempere AP, Raptis R, Prefasi D, Selchen D, Maurino J.

BMC Neurol. 2016 May 4;16:58. doi: 10.1186/s12883-016-0577-4.

9.

Rapid Assessment and Treatment of Transient Ischemic Attacks and Minor Stroke in Canadian Emergency Departments: Time for a Paradigm Shift.

Kamal N, Hill MD, Blacquiere DP, Boulanger JM, Boyle K, Buck B, Butcher K, Camden MC, Casaubon LK, Côté R, Demchuk AM, Dowlatshahi D, Dubuc V, Field TS, Ghrooda E, Gioia L, Gladstone DJ, Goyal M, Gubitz GJ, Harris D, Hart RG, Hunter G, Jeerakathil T, Jin A, Khan K, Lang E, Lanthier S, Lindsay MP, Mackey A, Mandzia J, Mehdiratta M, Minuk J, Oczkowski W, Odier C, Penn A, Perry J, Pettersen JA, Phillips SJ, Poppe AY, Saposnik G, Selchen D, Shamy M, Sharma M, Shoamanesh A, Shuaib A, Silver F, Stotts G, Swartz R, Tamayo A, Teitelbaum J, Verreault S, Wein T, Yip S, Coutts SB.

Stroke. 2015 Oct;46(10):2987-90. doi: 10.1161/STROKEAHA.115.010454. Epub 2015 Aug 27. No abstract available.

10.

Eosinophilic CNS vasculitis can mimic demyelinating disease of the brain and spinal cord.

Schneider R, Tsai JP, Munoz DG, Selchen DH.

Neurology. 2015 Feb 3;84(5):543-4. doi: 10.1212/WNL.0000000000001203. No abstract available.

11.

Anti-JC Virus Antibody Prevalence in Canadian MS Patients.

Bhan V, Lapierre Y, Freedman MS, Duquette P, Selchen D, Migounov V, Walt L, Zhang A.

Can J Neurol Sci. 2014 Nov;41(6):748-52. doi: 10.1017/cjn.2014.32. Epub 2014 Nov 4.

PMID:
25377521
12.

Good is not Good Enough: The Benchmark Stroke Door-to-Needle Time Should be 30 Minutes.

Kamal N, Benavente O, Boyle K, Buck B, Butcher K, Casaubon LK, Côté R, Demchuk AM, Deschaintre Y, Dowlatshahi D, Gubitz GJ, Hunter G, Jeerakathil T, Jin A, Lang E, Lanthier S, Lindsay P, Newcommon N, Mandzia J, Norris CM, Oczkowski W, Odier C, Phillips S, Poppe AY, Saposnik G, Selchen D, Shuaib A, Silver F, Smith EE, Stotts G, Suddes M, Swartz RH, Teal P, Watson T, Hill MD.

Can J Neurol Sci. 2014 Nov;41(6):694-6. doi: 10.1017/cjn.2014.41. Epub 2014 Oct 20. Review. No abstract available.

PMID:
25376123
13.

Atrial fibrillation in patients with cryptogenic stroke.

Gladstone DJ, Spring M, Dorian P, Panzov V, Thorpe KE, Hall J, Vaid H, O'Donnell M, Laupacis A, Côté R, Sharma M, Blakely JA, Shuaib A, Hachinski V, Coutts SB, Sahlas DJ, Teal P, Yip S, Spence JD, Buck B, Verreault S, Casaubon LK, Penn A, Selchen D, Jin A, Howse D, Mehdiratta M, Boyle K, Aviv R, Kapral MK, Mamdani M; EMBRACE Investigators and Coordinators.

N Engl J Med. 2014 Jun 26;370(26):2467-77. doi: 10.1056/NEJMoa1311376.

14.

Utility of the Canadian Treatment Optimization Recommendations (TOR) in MS care.

Grand'Maison F, Bhan V, Freedman MS, Myles ML, Patry DG, Selchen DH, Moriarty P, Traboulsee AL.

Can J Neurol Sci. 2013 Jul;40(4):527-35.

PMID:
23786735
15.

Treatment optimization in MS: Canadian MS Working Group updated recommendations.

Freedman MS, Selchen D, Arnold DL, Prat A, Banwell B, Yeung M, Morgenthau D, Lapierre Y; Canadian Multiple Sclerosis Working Group.

Can J Neurol Sci. 2013 May;40(3):307-23. Review.

PMID:
23603165
16.

MS, MRI, and the 2010 McDonald criteria: a Canadian expert commentary.

Selchen D, Bhan V, Blevins G, Devonshire V, Duquette P, Grand'Maison F, Kremenchutzky M, Lapierre Y, Li D, von Riedemann SJ, Freedman M.

Neurology. 2012 Dec 4;79(23 Suppl 2):S1-15. doi: 10.1212/WNL.0b013e318277d144.

PMID:
23212280
17.

Prevalence of Fabry disease in young patients with cryptogenic ischemic stroke.

Dubuc V, Moore DF, Gioia LC, Saposnik G, Selchen D, Lanthier S.

J Stroke Cerebrovasc Dis. 2013 Nov;22(8):1288-92. doi: 10.1016/j.jstrokecerebrovasdis.2012.10.005. Epub 2012 Nov 17.

PMID:
23168217
18.

Bilateral medial medullary infarction: a systematic review.

Pongmoragot J, Parthasarathy S, Selchen D, Saposnik G.

J Stroke Cerebrovasc Dis. 2013 Aug;22(6):775-80. doi: 10.1016/j.jstrokecerebrovasdis.2012.03.010. Epub 2012 Apr 26. Review.

PMID:
22541608
19.

Delirium in acute stroke: a systematic review and meta-analysis.

Shi Q, Presutti R, Selchen D, Saposnik G.

Stroke. 2012 Mar;43(3):645-9. doi: 10.1161/STROKEAHA.111.643726. Epub 2012 Jan 19. Review.

20.

Fabry's disease: a prospective multicenter cohort study in young adults with cryptogenic stroke.

Saposnik G, Lanthier S, Mamdani M, Thorpe KE, Melo M, Pope K, Selchen D, Moore DF; Canadian Stroke Consortium; Stroke Outcome Research Canada (SORCan) Working Group.

Int J Stroke. 2012 Apr;7(3):265-73. doi: 10.1111/j.1747-4949.2011.00734.x. Epub 2012 Jan 20.

PMID:
22264232
21.

Treatment experience, burden, and unmet needs (TRIBUNE) in multiple sclerosis: the costs and utilities of MS patients in Canada.

Karampampa K, Gustavsson A, Miltenburger C, Kindundu CM, Selchen DH.

J Popul Ther Clin Pharmacol. 2012;19(1):e11-25. Epub 2012 Jan 10.

PMID:
22247419
22.

Risk factors, inpatient care, and outcomes of pneumonia after ischemic stroke.

Finlayson O, Kapral M, Hall R, Asllani E, Selchen D, Saposnik G; Canadian Stroke Network; Stroke Outcome Research Canada (SORCan) Working Group.

Neurology. 2011 Oct 4;77(14):1338-45. doi: 10.1212/WNL.0b013e31823152b1. Epub 2011 Sep 21.

PMID:
21940613
23.

Stroke unit care: does ischemic stroke subtype matter?

Saposnik G, Hassan KA, Selchen D, Fang J, Kapral MK, Smith EE; Investigators of the Registry of the Canadian Stroke Network for the Stroke Outcome Research Canada (SORCan - http://www.sorcan.ca) working group.

Int J Stroke. 2011 Jun;6(3):244-50. doi: 10.1111/j.1747-4949.2011.00604.x. Epub 2011 Apr 18.

PMID:
21557812
24.

Safety and feasibility of collateral blood flow augmentation after intravenous thrombolysis.

Emery DJ, Schellinger PD, Selchen D, Douen AG, Chan R, Shuaib A, Butcher KS.

Stroke. 2011 Apr;42(4):1135-7. doi: 10.1161/STROKEAHA.110.607846. Epub 2011 Feb 24.

25.

Blunt cerebrovascular injuries: diagnosis and management outcomes.

Wei CW, Montanera W, Selchen D, Lian J, Stevens C, de Tilly LN.

Can J Neurol Sci. 2010 Sep;37(5):574-9.

PMID:
21059501
26.

Do all ischemic stroke subtypes benefit from organized inpatient stroke care?

Smith EE, Hassan KA, Fang J, Selchen D, Kapral MK, Saposnik G; Registry of the Canadian Stroke Network (RCSN); Stroke Outcome Research Canada (SORCan) Working Group.

Neurology. 2010 Aug 3;75(5):456-62. doi: 10.1212/WNL.0b013e3181ebdd8d. Epub 2010 Jun 30.

27.

Socioeconomic status, hospital volume, and stroke fatality in Canada.

Saposnik G, Jeerakathil T, Selchen D, Baibergenova A, Hachinski V, Kapral MK; Stroke Outcome Research Canada Working Group.

Stroke. 2008 Dec;39(12):3360-6. doi: 10.1161/STROKEAHA.108.521344. Epub 2008 Sep 4.

28.

Saving costs using an ounce of prevention: introduction of a regional stroke prevention clinic.

Bisaillon S, Douen A, Neabel B, Pageau N, Selchen D.

Axone. 2006 Spring;27(3):29-33. Review.

PMID:
16764405
29.

Bringing innovation to stroke care: development of a comprehensive stroke unit.

Bisaillon S, Douloff C, Leblanc K, Pageau N, Selchen D, Woloshyn N.

Axone. 2004 Jun;25(4):12-7.

PMID:
15368879
30.

Treatment optimization in multiple sclerosis.

Freedman MS, Patry DG, Grand'Maison F, Myles ML, Paty DW, Selchen DH; Canadian MS Working Group.

Can J Neurol Sci. 2004 May;31(2):157-68. Review.

PMID:
15198439
31.

Posterior cortical dementia with alexia: neurobehavioural, MRI, and PET findings.

Freedman L, Selchen DH, Black SE, Kaplan R, Garnett ES, Nahmias C.

J Neurol Neurosurg Psychiatry. 1991 May;54(5):443-8.

Supplemental Content

Loading ...
Support Center